HighMark Wealth Management’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$111K Buy
+5,000
New +$110K 0.03% 117
2024
Q3
– Sell
-750
Closed -$21.6K – 609
2024
Q2
$21.6K Hold
750
– – 0.01% 195
2024
Q1
$21.9K Hold
750
– – 0.01% 189
2023
Q4
$24.4K Hold
750
– – 0.02% 176
2023
Q3
$24K Hold
750
– – 0.02% 159
2023
Q2
$32.9K Sell
750
-102
-12% -$4.7K 0.02% 143
2023
Q1
$37.7K Buy
852
+102
+14% +$4.51K 0.03% 155
2022
Q4
$29.8K Buy
750
+375
+100% +$15.6K 0.02% 137
2022
Q3
$17K Hold
375
– – 0.01% 180
2022
Q2
$16K Hold
375
– – 0.01% 188
2022
Q1
$20K Buy
+375
New +$19.2K 0.01% 179
2021
Q4
– Sell
-196
Closed -$13K – 513
2021
Q3
$13K Buy
196
+27
+16% +$1.75K 0.01% 224
2021
Q2
$11K Buy
169
+24
+17% +$1.38K 0.01% 241
2021
Q1
$7K Sell
145
-115
-44% -$5.52K 0.01% 299
2020
Q4
$11K Sell
260
-1,293
-83% -$59.3K 0.01% 215
2020
Q3
$71K Buy
1,553
+1,463
+1,626% +$67.9K 0.06% 86
2020
Q2
$4K Buy
+90
New +$4.05K ﹤0.01% 333

Other funds holding KIDS

HighMark Wealth Management's KIDS Position: Q3 2026 in Review

HighMark Wealth Management opened a new position in OrthoPediatrics (KIDS) in Q3 2026: 5,000 shares worth $111K. The stake represents 0.03% of the portfolio and ranks #117 among its holdings. This is a return to the name: HighMark Wealth Management previously reported a position in KIDS as recently as Q2 2024.

HighMark Wealth Management first reported a position in KIDS in Q2 2020 and has held it in 17 quarters since. 140 funds tracked by Wall St. Rank hold KIDS as of Q3 2026.

  • HighMark Wealth Management held 5,000 shares of OrthoPediatrics worth $111K as of Q3 2026.
  • OrthoPediatrics was a new HighMark Wealth Management position in Q3 2026.
  • OrthoPediatrics made up 0.03% of HighMark Wealth Management's portfolio in Q3 2026, its #117 holding.
  • HighMark Wealth Management first reported a position in OrthoPediatrics in Q2 2020 and has held it in 17 quarters since.
  • 140 funds tracked by Wall St. Rank held OrthoPediatrics as of Q3 2026.

Based on HighMark Wealth Management's 13F filing for Q3 2026, filed 17 Nov 2026.